ARCHIVES

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

This article is from The Cancer Letter archive.

Vol. 33 No. 46 | December 14, 2007

Download PDF Visit The Full Archive

Related Articles

FTE Shortage Hurting Cancer and AIDS Research, Advisors Told; NCI Seeks Major Share Of New Slots

October 14, 1988

Kulig Will Oversee Outcomes Research at NCCN

September 30, 2011

In Brief: CREG To Be Used In Viral Oncology, Nutrition, Cell Kinetics, Immunology, Rauscher Tells NCAB

April 4, 1975

In Brief: Beahrs Headed Team For President’s Surgery; Chiles Chairs HHS Appropriations Subcommittee

January 9, 1987

Two Breast Cancer Treatments Show Similar Benefit In Trial

December 30, 2005

Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas

April 27, 2012